Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 98 entries
Sorted by: Best Match Show Resources per page
Cations M2(O2CtBu)4+, where M = Mo and W, and MoW(O2CtBu)4+. Theoretical, spectroscopic, and structural investigations.

Inorganic chemistry

Chisholm MH, D'Acchioli JS, Pate BD, Patmore NJ, Dalal NS, Zipse DJ.
PMID: 15859287
Inorg Chem. 2005 Feb 21;44(4):1061-7. doi: 10.1021/ic049081g.

With the aid of density function theory, the molecular and electronic structures of the molecules Mo2(O2CMe)4, MoW(O2CMe)4, and W2(O2CMe)4 and their single-electron oxidized radical cations have been determined; this includes calculated observables such as v(MM) and the delta -->...

Cite
Chisholm MH, D'Acchioli JS, Pate BD, et al. Cations M2(O2CtBu)4+, where M = Mo and W, and MoW(O2CtBu)4+. Theoretical, spectroscopic, and structural investigations. Inorg Chem. 2005;44(4):1061-7doi: 10.1021/ic049081g.
Chisholm, M. H., D'Acchioli, J. S., Pate, B. D., Patmore, N. J., Dalal, N. S., & Zipse, D. J. (2005). Cations M2(O2CtBu)4+, where M = Mo and W, and MoW(O2CtBu)4+. Theoretical, spectroscopic, and structural investigations. Inorganic chemistry, 44(4), 1061-7. https://doi.org/10.1021/ic049081g
Chisholm, Malcolm H, et al. "Cations M2(O2CtBu)4+, where M = Mo and W, and MoW(O2CtBu)4+. Theoretical, spectroscopic, and structural investigations." Inorganic chemistry vol. 44,4 (2005): 1061-7. doi: https://doi.org/10.1021/ic049081g
Chisholm MH, D'Acchioli JS, Pate BD, Patmore NJ, Dalal NS, Zipse DJ. Cations M2(O2CtBu)4+, where M = Mo and W, and MoW(O2CtBu)4+. Theoretical, spectroscopic, and structural investigations. Inorg Chem. 2005 Feb 21;44(4):1061-7. doi: 10.1021/ic049081g. PMID: 15859287.
Copy Download .nbib Format: NLM
Kinetics of aggregation and growth processes of PEG-stabilised mono- and multivalent gold nanoparticles in highly concentrated halide solutions.

Faraday discussions

Stein B, Zopes D, Schmudde M, Schneider R, Mohsen A, Goroncy C, Mathur S, Graf C.
PMID: 25972038
Faraday Discuss. 2015;181:85-102. doi: 10.1039/c5fd00024f. Epub 2015 May 14.

5-6 nm gold nanoparticles were prepared by hydrolytic decomposition of [NMe4][Au(CF3)2] and functionalized in situ with mono- and multivalent thiolated PEG ligands. Time-dependent changes of the nanoparticles were monitored in aqueous NaCl, NaBr, and NaI solutions by UV-Vis spectroscopy,...

Cite
Stein B, Zopes D, Schmudde M, et al. Kinetics of aggregation and growth processes of PEG-stabilised mono- and multivalent gold nanoparticles in highly concentrated halide solutions. Faraday Discuss. 2015;181:85-102doi: 10.1039/c5fd00024f.
Stein, B., Zopes, D., Schmudde, M., Schneider, R., Mohsen, A., Goroncy, C., Mathur, S., & Graf, C. (2015). Kinetics of aggregation and growth processes of PEG-stabilised mono- and multivalent gold nanoparticles in highly concentrated halide solutions. Faraday discussions, 18185-102. https://doi.org/10.1039/c5fd00024f
Stein, Benjamin, et al. "Kinetics of aggregation and growth processes of PEG-stabilised mono- and multivalent gold nanoparticles in highly concentrated halide solutions." Faraday discussions vol. 181 (2015): 85-102. doi: https://doi.org/10.1039/c5fd00024f
Stein B, Zopes D, Schmudde M, Schneider R, Mohsen A, Goroncy C, Mathur S, Graf C. Kinetics of aggregation and growth processes of PEG-stabilised mono- and multivalent gold nanoparticles in highly concentrated halide solutions. Faraday Discuss. 2015;181:85-102. doi: 10.1039/c5fd00024f. Epub 2015 May 14. PMID: 25972038.
Copy Download .nbib Format: NLM
A novel approach for radiotherapy dose escalation in rectal cancer using online MR-guidance and rectal ultrasound gel filling - Rationale and first in human.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Gani C, Lo Russo M, Boeke S, Wegener D, Gatidis S, Butzer S, Boldt J, Mönnich D, Thorwarth D, Nikolaou K, Zips D, Nachbar M.
PMID: 34534612
Radiother Oncol. 2021 Nov;164:37-42. doi: 10.1016/j.radonc.2021.09.002. Epub 2021 Sep 14.

INTRODUCTION: Dose escalated radiotherapy has previously been investigated as a strategy to increase complete response rates in rectal cancer. However large safety margins are required using cone-beam computed tomography guided radiotherapy leading to high doses to organs at risk...

Cite
Gani C, Lo Russo M, Boeke S, et al. A novel approach for radiotherapy dose escalation in rectal cancer using online MR-guidance and rectal ultrasound gel filling - Rationale and first in human. Radiother Oncol. 2021;164:37-42doi: 10.1016/j.radonc.2021.09.002.
Gani, C., Lo Russo, M., Boeke, S., Wegener, D., Gatidis, S., Butzer, S., Boldt, J., Mönnich, D., Thorwarth, D., Nikolaou, K., Zips, D., & Nachbar, M. (2021). A novel approach for radiotherapy dose escalation in rectal cancer using online MR-guidance and rectal ultrasound gel filling - Rationale and first in human. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 16437-42. https://doi.org/10.1016/j.radonc.2021.09.002
Gani, Cihan, et al. "A novel approach for radiotherapy dose escalation in rectal cancer using online MR-guidance and rectal ultrasound gel filling - Rationale and first in human." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 164 (2021): 37-42. doi: https://doi.org/10.1016/j.radonc.2021.09.002
Gani C, Lo Russo M, Boeke S, Wegener D, Gatidis S, Butzer S, Boldt J, Mönnich D, Thorwarth D, Nikolaou K, Zips D, Nachbar M. A novel approach for radiotherapy dose escalation in rectal cancer using online MR-guidance and rectal ultrasound gel filling - Rationale and first in human. Radiother Oncol. 2021 Nov;164:37-42. doi: 10.1016/j.radonc.2021.09.002. Epub 2021 Sep 14. PMID: 34534612.
Copy Download .nbib Format: NLM
Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI.

Cancers

Almansour H, Afat S, Fritz V, Schick F, Nachbar M, Thorwarth D, Zips D, Müller AC, Nikolaou K, Othman AE, Wegener D.
PMID: 33810410
Cancers (Basel). 2021 Mar 26;13(7). doi: 10.3390/cancers13071533.

The objective of this study is to conduct a qualitative and a quantitative image quality and lesion evaluation in patients undergoing MR-guided radiation therapy (MRgRT) for prostate cancer on a hybrid magnetic resonance imaging and linear accelerator system (MR-Linac...

Cite
Almansour H, Afat S, Fritz V, et al. Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI. Cancers (Basel). 2021;13(7)doi: 10.3390/cancers13071533.
Almansour, H., Afat, S., Fritz, V., Schick, F., Nachbar, M., Thorwarth, D., Zips, D., Müller, A. C., Nikolaou, K., Othman, A. E., & Wegener, D. (2021). Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI. Cancers, 13(7), . https://doi.org/10.3390/cancers13071533
Almansour, Haidara, et al. "Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI." Cancers vol. 13,7 (2021). doi: https://doi.org/10.3390/cancers13071533
Almansour H, Afat S, Fritz V, Schick F, Nachbar M, Thorwarth D, Zips D, Müller AC, Nikolaou K, Othman AE, Wegener D. Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI. Cancers (Basel). 2021 Mar 26;13(7). doi: 10.3390/cancers13071533. PMID: 33810410; PMCID: PMC8036991.
Copy Download .nbib Format: NLM
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer.

Cancers

Ott OJ, Gani C, Lindner LH, Schmidt M, Lamprecht U, Abdel-Rahman S, Hinke A, Weissmann T, Hartmann A, Issels RD, Zips D, Belka C, Grützmann R, Fietkau R.
PMID: 33805731
Cancers (Basel). 2021 Mar 13;13(6). doi: 10.3390/cancers13061279.

BACKGROUND: To prospectively analyze feasibility and pathological complete response (pCR) rates of neoadjuvant chemoradiotherapy combined with regional hyperthermia (RHT) in patients with locally advanced (LARC) or recurrent (LRRC) rectal cancer.METHODS: between 2012 and 2018, 111 patients with UICC stage...

Cite
Ott OJ, Gani C, Lindner LH, et al. Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer. Cancers (Basel). 2021;13(6)doi: 10.3390/cancers13061279.
Ott, O. J., Gani, C., Lindner, L. H., Schmidt, M., Lamprecht, U., Abdel-Rahman, S., Hinke, A., Weissmann, T., Hartmann, A., Issels, R. D., Zips, D., Belka, C., Grützmann, R., & Fietkau, R. (2021). Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer. Cancers, 13(6), . https://doi.org/10.3390/cancers13061279
Ott, Oliver J, et al. "Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer." Cancers vol. 13,6 (2021). doi: https://doi.org/10.3390/cancers13061279
Ott OJ, Gani C, Lindner LH, Schmidt M, Lamprecht U, Abdel-Rahman S, Hinke A, Weissmann T, Hartmann A, Issels RD, Zips D, Belka C, Grützmann R, Fietkau R. Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer. Cancers (Basel). 2021 Mar 13;13(6). doi: 10.3390/cancers13061279. PMID: 33805731; PMCID: PMC8001688.
Copy Download .nbib Format: NLM
Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC.

Cancers

Leger S, Zwanenburg A, Leger K, Lohaus F, Linge A, Schreiber A, Kalinauskaite G, Tinhofer I, Guberina N, Guberina M, Balermpas P, von der Grün J, Ganswindt U, Belka C, Peeken JC, Combs SE, Boeke S, Zips D, Richter C, Krause M, Baumann M, Troost EGC, Löck S.
PMID: 33086761
Cancers (Basel). 2020 Oct 19;12(10). doi: 10.3390/cancers12103047.

Imaging features for radiomic analyses are commonly calculated from the entire gross tumour volume (GTV

Cite
Leger S, Zwanenburg A, Leger K, et al. Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC. Cancers (Basel). 2020;12(10)doi: 10.3390/cancers12103047.
Leger, S., Zwanenburg, A., Leger, K., Lohaus, F., Linge, A., Schreiber, A., Kalinauskaite, G., Tinhofer, I., Guberina, N., Guberina, M., Balermpas, P., von der Grün, J., Ganswindt, U., Belka, C., Peeken, J. C., Combs, S. E., Boeke, S., Zips, D., Richter, C., Krause, M., Baumann, M., Troost, E. G. C., & Löck, S. (2020). Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC. Cancers, 12(10), . https://doi.org/10.3390/cancers12103047
Leger, Stefan, et al. "Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC." Cancers vol. 12,10 (2020). doi: https://doi.org/10.3390/cancers12103047
Leger S, Zwanenburg A, Leger K, Lohaus F, Linge A, Schreiber A, Kalinauskaite G, Tinhofer I, Guberina N, Guberina M, Balermpas P, von der Grün J, Ganswindt U, Belka C, Peeken JC, Combs SE, Boeke S, Zips D, Richter C, Krause M, Baumann M, Troost EGC, Löck S. Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC. Cancers (Basel). 2020 Oct 19;12(10). doi: 10.3390/cancers12103047. PMID: 33086761; PMCID: PMC7589463.
Copy Download .nbib Format: NLM
Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac - Feasibility, workflow data and patient acceptance.

Clinical and translational radiation oncology

Gani C, Boeke S, McNair H, Ehlers J, Nachbar M, Mönnich D, Stolte A, Boldt J, Marks C, Winter J, Künzel LA, Gatidis S, Bitzer M, Thorwarth D, Zips D.
PMID: 33319073
Clin Transl Radiat Oncol. 2020 Nov 30;26:55-61. doi: 10.1016/j.ctro.2020.11.014. eCollection 2021 Jan.

INTRODUCTION: Stereotactic body radiotherapy (SBRT) is an established ablative treatment for liver tumors with excellent local control rates. Magnetic resonance imaging guided radiotherapy (MRgRT) provides superior soft tissue contrast and may therefore facilitate a marker-less liver SBRT workflow. The...

Cite
Gani C, Boeke S, McNair H, et al. Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac - Feasibility, workflow data and patient acceptance. Clin Transl Radiat Oncol. 2020;26:55-61doi: 10.1016/j.ctro.2020.11.014.
Gani, C., Boeke, S., McNair, H., Ehlers, J., Nachbar, M., Mönnich, D., Stolte, A., Boldt, J., Marks, C., Winter, J., Künzel, L. A., Gatidis, S., Bitzer, M., Thorwarth, D., & Zips, D. (2021). Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac - Feasibility, workflow data and patient acceptance. Clinical and translational radiation oncology, 2655-61. https://doi.org/10.1016/j.ctro.2020.11.014
Gani, Cihan, et al. "Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac - Feasibility, workflow data and patient acceptance." Clinical and translational radiation oncology vol. 26 (2021): 55-61. doi: https://doi.org/10.1016/j.ctro.2020.11.014
Gani C, Boeke S, McNair H, Ehlers J, Nachbar M, Mönnich D, Stolte A, Boldt J, Marks C, Winter J, Künzel LA, Gatidis S, Bitzer M, Thorwarth D, Zips D. Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac - Feasibility, workflow data and patient acceptance. Clin Transl Radiat Oncol. 2020 Nov 30;26:55-61. doi: 10.1016/j.ctro.2020.11.014. eCollection 2021 Jan. PMID: 33319073; PMCID: PMC7723999.
Copy Download .nbib Format: NLM
Primary immunosuppressive TNI-based conditioning regimens in pediatric patients treated with haploidentical hematopoietic cell transplantation.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Wegener D, Lang P, Paulsen F, Weidner N, Zips D, Ebinger M, Holzer U, Döring M, Heinzelmann F.
PMID: 34476532
Strahlenther Onkol. 2022 Jan;198(1):66-72. doi: 10.1007/s00066-021-01840-y. Epub 2021 Sep 02.

PURPOSE: This retrospective analysis aims to address the toxicity and efficacy of a modified total nodal irradiation (TNI)-based conditioning regimen before haploidentical hematopoietic cell transplantation (HCT) in pediatric patients.MATERIALS AND METHODS: Patient data including long-term follow-up were evaluated of...

Cite
Wegener D, Lang P, Paulsen F, et al. Primary immunosuppressive TNI-based conditioning regimens in pediatric patients treated with haploidentical hematopoietic cell transplantation. Strahlenther Onkol. 2021;198(1):66-72doi: 10.1007/s00066-021-01840-y.
Wegener, D., Lang, P., Paulsen, F., Weidner, N., Zips, D., Ebinger, M., Holzer, U., Döring, M., & Heinzelmann, F. (2022). Primary immunosuppressive TNI-based conditioning regimens in pediatric patients treated with haploidentical hematopoietic cell transplantation. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 198(1), 66-72. https://doi.org/10.1007/s00066-021-01840-y
Wegener, D, et al. "Primary immunosuppressive TNI-based conditioning regimens in pediatric patients treated with haploidentical hematopoietic cell transplantation." Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] vol. 198,1 (2022): 66-72. doi: https://doi.org/10.1007/s00066-021-01840-y
Wegener D, Lang P, Paulsen F, Weidner N, Zips D, Ebinger M, Holzer U, Döring M, Heinzelmann F. Primary immunosuppressive TNI-based conditioning regimens in pediatric patients treated with haploidentical hematopoietic cell transplantation. Strahlenther Onkol. 2022 Jan;198(1):66-72. doi: 10.1007/s00066-021-01840-y. Epub 2021 Sep 02. PMID: 34476532.
Copy Download .nbib Format: NLM
Correction to: Value of PET imaging for radiation therapy.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC.
PMID: 34617130
Strahlenther Onkol. 2022 Jan;198(1):80-82. doi: 10.1007/s00066-021-01851-9.

No abstract available.

Cite
Lapa C, Nestle U, Albert NL, et al. Correction to: Value of PET imaging for radiation therapy. Strahlenther Onkol. 2022;198(1):80-82doi: 10.1007/s00066-021-01851-9.
Lapa, C., Nestle, U., Albert, N. L., Baues, C., Beer, A., Buck, A., Budach, V., Bütof, R., Combs, S. E., Derlin, T., Eiber, M., Fendler, W. P., Furth, C., Gani, C., Gkika, E., Grosu, A. L., Henkenberens, C., Ilhan, H., Löck, S., Marnitz-Schulze, S., Miederer, M., Mix, M., Nicolay, N. H., Niyazi, M., Pöttgen, C., Rödel, C. M., Schatka, I., Schwarzenboeck, S. M., Todica, A. S., Weber, W., Wegen, S., Wiegel, T., Zamboglou, C., Zips, D., Zöphel, K., Zschaeck, S., Thorwarth, D., Troost, E. G. C. (2022). Correction to: Value of PET imaging for radiation therapy. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 198(1), 80-82. https://doi.org/10.1007/s00066-021-01851-9
Lapa, Constantin, et al. "Correction to: Value of PET imaging for radiation therapy." Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] vol. 198,1 (2022): 80-82. doi: https://doi.org/10.1007/s00066-021-01851-9
Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC. Correction to: Value of PET imaging for radiation therapy. Strahlenther Onkol. 2022 Jan;198(1):80-82. doi: 10.1007/s00066-021-01851-9. PMID: 34617130.
Copy Download .nbib Format: NLM
Erratum to: Hypofractionated radiotherapy for localized prostate cancer.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Höcht S, Aebersold DM, Albrecht C, Böhmer D, Flentje M, Ganswindt U, Hölscher T, Martin T, Sedlmayer F, Wenz F, Zips D, Wiegel T.
PMID: 27752707
Strahlenther Onkol. 2016 Nov;192(11):830. doi: 10.1007/s00066-016-1054-0.

No abstract available.

Cite
Höcht S, Aebersold DM, Albrecht C, et al. Erratum zu: Hypofraktionierte Radiotherapie des lokalisierten Prostatakarzinoms. Erratum to: Hypofractionated radiotherapy for localized prostate cancer. Strahlenther Onkol. 2016;192(11):830doi: 10.1007/s00066-016-1054-0.
Höcht, S., Aebersold, D. M., Albrecht, C., Böhmer, D., Flentje, M., Ganswindt, U., Hölscher, T., Martin, T., Sedlmayer, F., Wenz, F., Zips, D., & Wiegel, T. (2016). Erratum zu: Hypofraktionierte Radiotherapie des lokalisierten Prostatakarzinoms. Erratum to: Hypofractionated radiotherapy for localized prostate cancer. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 192(11), 830. https://doi.org/10.1007/s00066-016-1054-0
Höcht, Stefan, et al. "Erratum zu: Hypofraktionierte Radiotherapie des lokalisierten Prostatakarzinoms." Erratum to: Hypofractionated radiotherapy for localized prostate cancer. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] vol. 192,11 (2016): 830. doi: https://doi.org/10.1007/s00066-016-1054-0
Höcht S, Aebersold DM, Albrecht C, Böhmer D, Flentje M, Ganswindt U, Hölscher T, Martin T, Sedlmayer F, Wenz F, Zips D, Wiegel T. Erratum zu: Hypofraktionierte Radiotherapie des lokalisierten Prostatakarzinoms. Erratum to: Hypofractionated radiotherapy for localized prostate cancer. Strahlenther Onkol. 2016 Nov;192(11):830. doi: 10.1007/s00066-016-1054-0. PMID: 27752707; PMCID: PMC6828495.
Copy Download .nbib Format: NLM
Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations : An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO).

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Dapper H, Belka C, Bock F, Budach V, Budach W, Christiansen H, Debus J, Distel L, Dunst J, Eckert F, Eich H, Eicheler W, Engenhart-Cabillic R, Fietkau R, Fleischmann DF, Frerker B, Giordano FA, Grosu AL, Herfarth K, Hildebrandt G, Kaul D, Kölbl O, Krause M, Krug D, Martin D, Matuschek C, Medenwald D, Nicolay NH, Niewald M, Oertel M, Petersen C, Pohl F, Raabe A, Rödel C, Rübe C, Schmalz C, Schmeel LC, Steinmann D, Stüben G, Thamm R, Vordermark D, Vorwerk H, Wiegel T, Zips D, Combs SE.
PMID: 34786605
Strahlenther Onkol. 2022 Jan;198(1):1-11. doi: 10.1007/s00066-021-01861-7. Epub 2021 Nov 16.

The new Medical Licensing Regulations 2025 (Ärztliche Approbationsordnung, ÄApprO) will soon be passed by the Federal Council (Bundesrat) and will be implemented step by step by the individual faculties in the coming months. The further development of medical studies...

Cite
Dapper H, Belka C, Bock F, et al. Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations : An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO). Strahlenther Onkol. 2021;198(1):1-11doi: 10.1007/s00066-021-01861-7.
Dapper, H., Belka, C., Bock, F., Budach, V., Budach, W., Christiansen, H., Debus, J., Distel, L., Dunst, J., Eckert, F., Eich, H., Eicheler, W., Engenhart-Cabillic, R., Fietkau, R., Fleischmann, D. F., Frerker, B., Giordano, F. A., Grosu, A. L., Herfarth, K., Hildebrandt, G., Kaul, D., Kölbl, O., Krause, M., Krug, D., Martin, D., Matuschek, C., Medenwald, D., Nicolay, N. H., Niewald, M., Oertel, M., Petersen, C., Pohl, F., Raabe, A., Rödel, C., Rübe, C., Schmalz, C., Schmeel, L. C., Steinmann, D., Stüben, G., Thamm, R., Vordermark, D., Vorwerk, H., Wiegel, T., Zips, D., & Combs, S. E. (2022). Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations : An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO). Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 198(1), 1-11. https://doi.org/10.1007/s00066-021-01861-7
Dapper, H, et al. "Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations : An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO)." Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] vol. 198,1 (2022): 1-11. doi: https://doi.org/10.1007/s00066-021-01861-7
Dapper H, Belka C, Bock F, Budach V, Budach W, Christiansen H, Debus J, Distel L, Dunst J, Eckert F, Eich H, Eicheler W, Engenhart-Cabillic R, Fietkau R, Fleischmann DF, Frerker B, Giordano FA, Grosu AL, Herfarth K, Hildebrandt G, Kaul D, Kölbl O, Krause M, Krug D, Martin D, Matuschek C, Medenwald D, Nicolay NH, Niewald M, Oertel M, Petersen C, Pohl F, Raabe A, Rödel C, Rübe C, Schmalz C, Schmeel LC, Steinmann D, Stüben G, Thamm R, Vordermark D, Vorwerk H, Wiegel T, Zips D, Combs SE. Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations : An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO). Strahlenther Onkol. 2022 Jan;198(1):1-11. doi: 10.1007/s00066-021-01861-7. Epub 2021 Nov 16. PMID: 34786605; PMCID: PMC8594460.
Copy Download .nbib Format: NLM
Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population.

Radiology and oncology

Potkrajcic V, Traub F, Hermes B, Scharpf M, Kolbenschlag J, Zips D, Paulsen F, Eckert F.
PMID: 34821137
Radiol Oncol. 2021 Nov 19;55(4):459-466. doi: 10.2478/raon-2021-0038.

BACKGROUND: Standard therapy for localised, resectable high risk soft tissue sarcomas consists of wide excision and radiotherapy over several weeks. This treatment schedule is hardly feasible in geriatric and frail patients. In order not to withhold radiotherapy from these...

Cite
Potkrajcic V, Traub F, Hermes B, et al. Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population. Radiol Oncol. 2021;55(4):459-466doi: 10.2478/raon-2021-0038.
Potkrajcic, V., Traub, F., Hermes, B., Scharpf, M., Kolbenschlag, J., Zips, D., Paulsen, F., & Eckert, F. (2021). Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population. Radiology and oncology, 55(4), 459-466. https://doi.org/10.2478/raon-2021-0038
Potkrajcic, Vlatko, et al. "Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population." Radiology and oncology vol. 55,4 (2021): 459-466. doi: https://doi.org/10.2478/raon-2021-0038
Potkrajcic V, Traub F, Hermes B, Scharpf M, Kolbenschlag J, Zips D, Paulsen F, Eckert F. Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population. Radiol Oncol. 2021 Nov 19;55(4):459-466. doi: 10.2478/raon-2021-0038. PMID: 34821137.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 98 entries